remember this? "3D animations are great support to explain the mechanism of action of a molecule. With the help of Amerra, we were able to convey how our promising peptide-drug conjugate technology works inside the body. Amerra produced such an amazing result at a cost a small biotech like us can afford. We're very much looking forward to working with them on our next animated video."
- Nichol Pelchat, Associate Director, New Product Planning
https://youtu.be/6iu07e1_us8
Yet they are quite generous with their compensations which was announced on a Friday afternoon thus less attention. So whose interest has been prioritized using the funds for a cash strapped company? the employees with fat bonuses or decent marketing to support the valuation of the company subsequently a decent ROI for their loyal long-term shareholders?